tradingkey.logo
tradingkey.logo
Buscar

United-Guardian Inc

UG
Añadir a la lista de seguimiento
7.110USD
-0.030-0.42%
Cierre 07/01, 16:00ETCotizaciones retrasadas 15 min
32.44MCap. mercado
13.82P/E TTM

Más Datos de United-Guardian Inc Compañía

United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.

Información de United-Guardian Inc

Símbolo de cotizaciónUG
Nombre de la empresaUnited-Guardian Inc
Fecha de salida a bolsaMar 17, 1980
Director ejecutivo- -
Número de empleados24
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 17
Dirección230 Marcus Blvd
CiudadHAUPPAUGE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal11788
Teléfono16312730900
Sitio Webhttps://u-g.com/
Símbolo de cotizaciónUG
Fecha de salida a bolsaMar 17, 1980
Director ejecutivo- -

Ejecutivos de United-Guardian Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kenneth H. (Ken) Globus
Mr. Kenneth H. (Ken) Globus
Chairman of the Board
Chairman of the Board
1.31M
-0.57%
Mr. Arthur M. Dresner
Mr. Arthur M. Dresner
Independent Director
Independent Director
12.18K
--
Mr. Lawrence F. Maietta, CPA
Mr. Lawrence F. Maietta, CPA
Independent Director
Independent Director
4.00K
--
Mr. Andrew A. Boccone
Mr. Andrew A. Boccone
Independent Director
Independent Director
--
--
Mr. Peter A. Hiltunen
Mr. Peter A. Hiltunen
Senior Vice President, Production and Procurement
Senior Vice President, Production and Procurement
--
--
Mr. S. Ari Papoulias
Mr. S. Ari Papoulias
Independent Director
Independent Director
--
--
Ms. Andrea J. Young
Ms. Andrea J. Young
Principal Financial Officer, Controller, Treasurer and Secretary
Principal Financial Officer, Controller, Treasurer and Secretary
--
--
Ms. Donna Vigilante
Ms. Donna Vigilante
President, Director
President, Director
--
-100.00%
Ms. Catherine Joy Kolinski
Ms. Catherine Joy Kolinski
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kenneth H. (Ken) Globus
Mr. Kenneth H. (Ken) Globus
Chairman of the Board
Chairman of the Board
1.31M
-0.57%
Mr. Arthur M. Dresner
Mr. Arthur M. Dresner
Independent Director
Independent Director
12.18K
--
Mr. Lawrence F. Maietta, CPA
Mr. Lawrence F. Maietta, CPA
Independent Director
Independent Director
4.00K
--
Mr. Andrew A. Boccone
Mr. Andrew A. Boccone
Independent Director
Independent Director
--
--
Mr. Peter A. Hiltunen
Mr. Peter A. Hiltunen
Senior Vice President, Production and Procurement
Senior Vice President, Production and Procurement
--
--
Mr. S. Ari Papoulias
Mr. S. Ari Papoulias
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de United-Guardian Inc?

Los cinco principales accionistas de United-Guardian Inc son: Mr. Kenneth H. (Ken) Globus

¿Cuántas instituciones poseen acciones de United-Guardian Inc (UG)?

A fecha de 2026Q1, 54 instituciones poseen acciones de United-Guardian Inc, con un valor de mercado combinado de aproximadamente 1.13M, lo que representa el 24.63% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 24048.00.

¿Cuál es la mayor fuente de ganancias de United-Guardian Inc?

El 2026Q1, el segmento empresarial Pharmaceutical generó la ganancia más alta para United-Guardian Inc, ascendiendo a 6.23M y representando el 59.04% de la ganancia total.